Psychiatric Research At Risk?

November 17, 1998

The American Psychiatric Association commends efforts but questions some recommendations in the National Bioethics Advisory Commission research guidelines report released today. To obtain APA and advocacy group statements, a summary of key issues, and an expert contacts list, call the APA's FastFax line, 888-267-5400, and request document # 6130. To chat on-line about the issue, leave bulletin board messages, and arrange interviews, visit APA's Psychwise interactive website for journalists and psychiatrists. Go to www.psych.org and hit PSYCHWISE Media D-O-Cs Interactive.
-end-


American Psychiatric Association

Related Advocacy Group Statements Articles from Brightsurf:

Key priorities for transplant and living donor advocacy during COVID-1
Researchers describe ways to achieve optimal patient advocacy for kidney recipients and donors during the COVID-19 pandemic and beyond.

Two new AHA statements focus on heart failure: How social determinants can affect outcomes; impact on caregivers
Adverse social factors, such as insurance status, food insecurity, lack of funds for medication and others, may lead to worse heart failure outcomes.

Groups publish statements on CT contrast use in patients with kidney disease
The risk of administering modern intravenous iodinated contrast media in patients with reduced kidney function has been overstated, according to new consensus statements from the American College of Radiology and the National Kidney Foundation.

Regenstrief faculty discuss communication and patient advocacy at national meeting
Regenstrief Institute research scientists are presenting some of the institute's latest research on patient engagement and advocacy at the Society of General Internal Medicine Annual Meeting in Washington, D.C., May 8-11.

ACR targets step therapy and drug pricing in new position statements
The American College of Rheumatology (ACR) has released new drug pricing and step therapy position statements that they hope legislators will consider as they continue to explore policy and regulatory options to make drugs more affordable and accessible.

US patient advocacy groups received majority of pharma donations in multi-country study
A new study by Johns Hopkins Bloomberg School of Public Health researchers found that U.S.-based patient advocacy organizations received a disproportionate amount of contributions made by the world's 10 largest pharmaceutical companies in 2016.

Policy statements on the effects of media overlook scientific complexity
As different forms of media infuse everyday life, several organizations and associations have issued public statements about the effects of media exposure.

ESMO advocacy for patient-centred care takes on global dimension
Supportive and palliative care should be an integral part of cancer treatment (ESMO Position Paper, 2017).

Two new USPSTF recommendation statements
In two new statements, theĀ US Preventive Services Task Force (USPSTF) concludes current evidence is insufficient to make recommendations assessing cardiovascular disease (CVD) risk with certain nontraditional risk factors and screening for peripheral artery disease (PAD) and CVD risk with the ankle-brachial index (ABI).

At what size does a minority group become influential?
When a viewpoint is held by a minority, what size does that minority need to reach to hit a tipping point, where their view becomes widely accepted in the rest of the population?

Read More: Advocacy Group Statements News and Advocacy Group Statements Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.